Synthesis of Arylpiperazine-Based CNS Ligands: Batch Disconnections and Their Continuous-Flow Implementation. [PDF]
MoleculesJeong D +5 more
europepmc +1 more source
Conformations and Physicochemical Properties of Biological Ligands in Various Environments. [PDF]
Int J Mol Sci, 2023 Le Questel JY.
europepmc +1 more source
Arylpiperazine Derivative NAF19 Inhibits Prostate Cancer Activity and Its Molecular Mechanisms. [PDF]
Drugs R DJiang H, Xu M, Jiang S, Huang W.
europepmc +1 more source
Recent Advances in Biomembrane Models for Studying Interactions with Bio-/Molecules. [PDF]
Membranes (Basel)Maniewska J, Gębczak K.
europepmc +1 more source
New Oxicam Derivatives-Studies of Membrane Interactions, Cytotoxicity, Cyclooxygenase Inhibition and Molecular Docking. [PDF]
Membranes (Basel)Maniewska J +4 more
europepmc +1 more source
Solvates of New Arylpiperazine Salicylamide Derivative-a Multi-Technique Approach to the Description of 5 HTR Ligand Structure and Interactions. [PDF]
Int J Mol Sci, 2021 Pindelska E +3 more
europepmc +1 more source
Antimalarials based on the arylpiperazine privileged substructure
, 2005 Based on a previous study, arylpiperazines (2-chlorophenylpiperazine, 2-ethoxyphenylpiperazine and phenylpiperazine) were found to be significantly more potent against the chloroquine-resistant (K1) strain than against the chloroquine-sensitive(DIO) strain.
openaire +1 more source
The Structural Determinants for α1-Adrenergic/Serotonin Receptors Activity among Phenylpiperazine-Hydantoin Derivatives. [PDF]
Molecules, 2021 Kucwaj-Brysz K +8 more
europepmc +1 more source
Synthesis, bioactivity, and molecular docking studies: novel arylpiperazine derivatives as potential new-resistant AR antagonists. [PDF]
Front ChemJiang H, Chen H, Wang Y, Xu H, Chen H.
europepmc +1 more source
Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer. [PDF]
Molecules, 2021 Lewandowska P +8 more
europepmc +1 more source